Excluding the exceptional items, adjusted net profit for the fourth quarter last fiscal stood at Rs 2,156 crore, up 36 per cent, over the fourth quarter of 2021-22 fiscal, Sun Pharma said in a regulatory filing.
Read more about Sun Pharma dips 3% on profit booking post March quarter results on Business Standard. In the past three months, the stock outperformed the market by gaining nearly 20 per cent, as compared to 4.6 per cent rise in the S&P BSE Sensex, till Thursday